HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 275, Issue 32, 24547-24551, August 11, 2000

This Article Abstract Full Text (PDF) All Versions of this Article: 275/32/24547    most recent C000177200v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dienz, O. Articles by Schmitz, M. L. Search for Related Content PubMed PubMed Citation Articles by Dienz, O. Articles by Schmitz, M. L. Social Bookmarking                      What's this?

Synergistic Activation of NF-B by Functional Cooperation between Vav and PKC in T Lymphocytes^*

Oliver Dienz, Steffen P. Hehner, Wulf Dröge, and M. Lienhard Schmitz

From the German Cancer Research Center, Department of Immunochemistry (G0200), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany

Received for publication, March 15, 2000, and in revised form, June 1, 2000

	ABSTRACT

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

Here we identified PKC as an activator of transcription factor NF-B in T cells. PKC-induced NF-B activation was synergistically augmented by Vav. Several experimental approaches revealed that PKC is located downstream from Vav in the control of the pathway leading to synergistic NF-B activation. In addition to the synergistic activation cascade, Vav also triggered NF-B activity on a separate route. CD3/CD28-induced activation of NF-B was inhibited by dominant negative forms of Vav or PKC, revealing their essential role in this activation pathway. The Vav/PKC-mediated signals preferentially activated IB kinase . Vav and PKC were found to be constitutively associated in unstimulated T cells. Only the ligation of the costimulatory CD28 receptor, but not of the T cell receptor, resulted in the transient dissociation of the Vav-PKC complex. In contrast, T cell receptor/CD28 costimulation resulted in faster dissociation and slower reassociation kinetics.

	INTRODUCTION

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

Full activation of T cells relies on the simultaneous delivery of signals provided by the TCR¹-CD3- complex and auxiliary receptors such as CD28 (1). Receptor ligation triggers the activation of protein tyrosine kinases (PTKs) including Lck, that induce the tyrosine phosphorylation of multiple target proteins, thus enabling the formation of multi-protein complexes. These aggregates contain adaptor proteins such as LAT or SLP76 and signaling molecules including Vav and PLC (2). Activated PLC produces inositol triphosphate, which leads to the release of Ca²⁺ and the production of diacylglycerol, which mediates activation of PKC family members (3). The Ca²⁺-independent novel PKC isoform  (4) is almost exclusively expressed in lymphoid cells and inducibly translocates to the zone of TCR clustering in the central core of the supramolecular activation complex (SMAC) present in the contact region between antigen-presenting cells and T cells (5). PKC is a potent activator of JNK (6) and cooperates with calcineurin for the activation of this kinase (7).

Tyrosine-phosphorylation of Vav mediates both activation and down-modulation of Vav effector functions (8). Activated Vav displays a GDP/GTP exchange factor (GEF) activity for Rac (9, 10), thereby coupling Vav to downstream Rac effector pathways. But there is also recent evidence for GEF-independent activation pathways of Vav, such as the Vav-mediated activation of nuclear factor AT (11). Gene disruption experiments revealed the importance of Vav for thymic selection, cytoskeletal reorganization, receptor-mediated proliferation, and the activation of NF-B (12, 13).

This transcription factor is trapped in the cytoplasm of unstimulated cells by association with an inhibitory IB protein (14). T cell costimulation leads to the activation of two homologous kinases, termed IKK and IKK (15). These kinases are contained in the IB kinase complex (IKC) and phosphorylate IB proteins, thus allowing ubiquitinylation and degradation of IB proteins, resulting in the subsequent activation of NF-B (16). IKKs are activated by IKK kinases (IKKKs) including MEKK1, NIK, and MLK3 and further signaling molecules, which remain to be identified (14). TCR/CD28-induced NF-B activation involves the Cot kinase, which activates the IKKs via NIK (17), as well as MLK3, a direct binding partner and activator of IKK and IKK (18).

There is recent evidence that Vav and PKC functionally interact in the process of TCR-induced T cell activation (19) and IL-4 transcription (20). We have previously shown that Vav and PKC target the P1 and PRE-I elements contained in the IL-4 promoter (20). Because both elements are bound by members of the NF-B family of transcription factors (21), we have tested the effects of Vav and PKC on NF-B activation. This study reveals that Vav and PKC cooperatively activate NF-B in T cells by targeting IKK.

	EXPERIMENTAL PROCEDURES

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

Antisera, Plasmids, and Reagents-- The following antibodies were purchased from the indicated suppliers: FLAG-M2, Sigma; Myc (9E10), Santa Cruz Biotechnology Inc.; Vav, Upstate Biotechnology; PKC, Transduction Laboratories; HA antibody (12CA5), Roche Molecular Biochemicals. The luciferase constructs (B)3-Luc (18) and expression vectors for FLAG-tagged Vav (22), PKC A/E, PKC K/R, IKK K/M, IKK K/A, MKK7 K/L, MLK3 K/R, SLP76 SH2, LAT YY/FF (20), MEKK1 K/M, NIK KK/AA (18), IKK (23), Cot K/M (17), RacN17 (24), MKK4 K/R (25), and Lck K/R (26) were as described.

Electrophoretic Mobility Shift Assays (EMSAs) and Luciferase Determination-- EMSAs were performed essentially as described (20). Equal amounts of protein were tested for DNA binding to the following oligonucleotide, which contains a single NF-B-binding site. The sense sequence is underlined: 5'-AGTTGAGGGGACTTTCCCAGGC-3'. Luciferase activity was measured using a luminometer (Duo Lumat LB 9507, Berthold) that was programmed to inject 50 µl of assay buffer and to measure light emission for 10 s after injection according to the instructions of the manufacturer (Promega Inc.). A -galactosidase reporter plasmid controlled by a constitutive Rous sarcoma virus promoter was cotransfected to ensure comparable transfection efficiencies.

Coprecipitation Experiments and Immunoblotting-- Cells were washed with phosphate-buffered saline, and the pellets were resuspended on ice for 15 min and for an additional 15 min at 37 °C in 250 µl of Triton X-100 lysis buffer (20 mM Tris/HCl, pH 7.5, 150 mM NaCl, 1 mM phenylmethylsulfonyl fluoride, 10 mM NaF, 0.5 mM sodium vanadate, leupeptin (10 µg/ml), aprotinin (10 µg/ml), 1% (v/v) Triton X-100, and 10% (v/v) glycerol). Cell debris was pelleted upon centrifugation, and extracts from antibody-stimulated cells were precleared with protein A/G-Sepharose. Equal amounts of protein contained in the supernatants were mixed with 1 to 2 µg of antibody and 25 µl of protein A/G-Sepharose and rotated for 4 h on a spinning wheel at 4 °C. The immunoprecipitates were washed 5 times in Triton X-100 lysis buffer and subsequently boiled in 1× SDS sample buffer prior to SDS polyacrylamide gel electrophoresis and further analysis by Western blotting as described (20).

Isolation of Primary T Cells, Cell Culture, Transfections, and Stimulations-- Peripheral blood lymphocytes were purified from heparinized peripheral blood of healthy donors by density centrifugation on Ficoll gradients (Lymphoprep Nycomed Pharma, Oslo, Norway). T cells were isolated by negative selection using antibodies specific for CD19 and CD14 and magnetic beads coated with sheep anti-mouse immunoglobulin. Stimulations with CD3 and/or CD28 antibodies were done essentially as published (27) and further analyzed as described above. Jurkat T leukemia cells expressing the large T antigen were grown at 37 °C in RPMI 1640 medium containing 10% (v/v) heat-inactivated fetal calf serum, 10 mM HEPES, 1% (v/v) penicillin/streptomycin (all from Life Technologies), 2 mg/ml G418, and 2 mM glutamine. Cells were electroporated using a gene pulser (Bio-Rad) at 950 microfarad/250 V. Stimulations were performed by adding agonistic CD3 (final concentration 10 µg/ml, clone OKT3) and/or CD28 (final concentration 10 µg/ml, clone 9.3) antibodies.

In Vitro Kinase Assays-- Immune complex kinases assays using the purified GST-IB- (1-54) substrate protein were performed as described (18).

	RESULTS

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

A possible cooperation between Vav and PKC for the activation of NF-B was tested by transfection of T cell leukemia Jurkat cells with an NF-B-dependent luciferase reporter gene together with increasing amounts of expression vectors for Vav and/or constitutively active PKC (PKC A/E) (Fig. 1A). Vav expression dose-dependently augmented NF-B activity, but PKC A/E activated NF-B even more potently. No activation of NF-B was seen upon expression of PKC, -, or -, revealing the importance of the PKC isoform  for NF-B activation in T cells (data not shown). However, coexpression of Vav and PKC A/E potently activated NF-B-dependent luciferase activity in a synergistic manner (Fig. 1A). To test whether this synergism is also apparent at the level of induced DNA binding, we transfected Jurkat cells with different combinations of expression vectors for Vav, PKC A/E, or the empty expression vector as a control. Cells were either left untreated or stimulated with CD3/CD28 antibodies, and NF-B DNA binding was determined by EMSAs. Expression of either Vav or PKC A/E alone induced DNA-binding of NF-B, but coexpression of both activators enhanced NF-B DNA binding (Fig. 1B). Costimulation with CD3/CD28 antibodies further triggered DNA binding activity of NF-B elicited by Vav, PKC A/E, or both (Fig. 1B). To test whether this synergistic activation of NF-B is mediated by the activation of the IKKs or via an IKK-independent mechanism (28, 29), we analyzed the impact of increasing amounts of coexpressed dominant negative (DN) forms of IKK and IKK on Vav/PKC A/E-induced NF-B activation in Jurkat cells. IKK K/A inhibited the Vav/PKC-submitted NF-B activation more completely than kinase-inactive IKK K/M (Fig. 2A). These results revealed that the Vav- and PKC-derived signals depend on IKK.

View larger version (39K): [in this window] [in a new window]   Fig. 1.   Synergistic activation of NF-B by Vav and PKC. A, Jurkat cells were transiently transfected with 5 µg of an NF-B reporter construct together with increasing amounts of Vav and/or PKC A/E at the indicated combinations. Luciferase activity was determined 18 h post-transfection. Gene expression is displayed as average -fold activation relative to vector-transfected cells. Results shown are averages of three independent experiments. B, Jurkat cells were transfected either with empty expression vector or with plasmids encoding Vav and/or PKC A/E at the indicated combinations. The next day, cells were stimulated for 4 h with CD3/CD28 antibodies as indicated, total cell extracts were prepared, and the DNA binding activity of NF-B was assayed by EMSAs (upper panel). An autoradiogram is displayed; the filled arrowhead indicates the location of the DNA-NF-B complex, the circle indicates the position of a constitutively active DNA-binding protein, and the triangle indicates the position of the unbound oligonucleotide. A sample of each lysate was analyzed by Western blotting (WB) for protein expression of Vav and PKC (lower panels).

View larger version (29K): [in this window] [in a new window]   Fig. 2.   Vav/PKC synergistically activate IKK. A, the indicated combinations of expression vectors for Vav and/or PKC A/E (5 µg, respectively) were transfected either alone or with increasing amounts of vectors encoding the kinase-dead forms of IKK or IKK and 5 µg of the NF-B-dependent luciferase reporter gene into Jurkat cells. 1 day post-transfection, cells were harvested and tested for luciferase activity and the expression of IKK and IKK. Results from luciferase assays are expressed as average -fold induction relative to unstimulated, vector-transfected cells. Bars indicate standard deviations; mean values of three independent experiments are shown. A fraction of the extract was analyzed by Western blotting for the occurrence of tagged IKK and IKK (lower panel). B, HA-tagged IKK (1 µg) was expressed either alone or in combination with PKC A/E and/or Vav in Jurkat cells. 18 h post-transfection, cell lysates were prepared, IKK was immunoprecipitated, and kinase activity was determined by immunecomplex kinase assays (KA) using purified GST-IB- (1-54) as substrate. An autoradiogram from a reducing SDS gel shows phosphorylation of the recombinant substrate protein and a quantitative evaluation obtained by phosphorimaging (upper panel). A fraction of the immunoprecipitate was analyzed by Western blotting as shown (lower panels). C, the experiment was performed as in B, with the exception that an expression vector for IKK was transfected.

To investigate whether Vav/PKC can lead to the activation of IKK kinase activity, Jurkat cells were transfected with various combinations of PKC A/E and Vav expression vectors together with a low amount of an HA-tagged IKK expression vector that allows its incorporation into functional high molecular weight IKCs.² The tagged IKK protein was immunoprecipitated,and the activity of coprecipitating IKKs was examined by measuring the phosphorylation of the exogenously added substrate protein (GST-IB- (1-54)) by immunecomplex kinase assays (Fig. 2B). These experiments revealed that the IKC was activated by Vav and even more by PKC A/E alone. However, the combined expression of both proteins strongly augmented the enzymatic activity of the IKC. The activation of IKK was investigated by employing a similar experimental approach with the exception that a tagged IKK protein was transfected instead of IKK (Fig. 2C). IKK activity induced by the individual proteins was strongly enhanced upon coexpression of both activators, revealing that the observed transcriptional synergism is also apparent at the kinase level. In contrast, neither PKC nor Vav were able to significantly induce IKK activity (data not shown).

The activation signals for the IKC are not completely understood, and the relative contributions of the three IKKKs described so far are not clear. We therefore investigated the role of all three IKKKs for the activation signals derived from Vav, PKC, or both. Jurkat cells were transfected with an NF-B-dependent reporter gene and various combinations of Vav and PKC A/E in the absence or presence of DN forms of NIK, MEKK1, and MLK3 (Fig. 3A). The Vav-derived signals were only partially inhibited by DN forms of each of the three IKKKs, raising the possibility that Vav activates the IKC by another, so far unknown pathway. In contrast, the PKC- and PKC/Vav-generated signals were absolutely dependent on NIK but only incompletely inhibited by DN forms of MEKK1 and MLK3. The upstream signaling events were further characterized by a similar experimental approach employing coexpression of DN forms of various signal transducing and adaptor proteins (Fig. 3A). DN forms of Rac and MKK4 interfered with Vav-mediated NF-B activation without affecting PKC- and Vav/PKC-induced activation pathways. DN forms of MKK7, Cot, Lck, and LAT preferentially inhibited PKC- and Vav/PKC-mediated signals. Surprisingly, coexpression of a SLP76 variant lacking the SH2 domain did not significantly affect Vav-mediated NF-B activation, but further boosted Vav/PKC-induced NF-B transcription. This behavior might be explained by the loss of an inhibitory interaction. We also tested the impact of pathway-specific inhibitory compounds on Vav- and/or PKC-induced NF-B activation. Cyclosporin A (which blocks Ca²⁺/calcineurin-dependent signaling events) and herbimycin A (a PTK inhibitor), interfered preferentially with Vav-derived signaling steps but did not inhibit PKC- and Vav/PKC-mediated NF-B activation (data not shown). In summary, these results suggest that any efficient inhibition of PKC is concomitant with the loss of Vav/PKC-mediated NF-B activation, suggesting that PKC acts downstream from Vav. To address this question directly, Jurkat cells were transfected with an NF-B-dependent luciferase reporter gene along with various combinations of active and inactive variants of Vav and PKC prior to stimulation with CD3/CD28 antibodies as indicated (Fig. 3B). NF-B-driven gene expression was augmented by Vav expression and further triggered upon T cell costimulation. NF-B-dependent transcription induced by Vav and/or CD3/CD28 was inhibited upon coexpression of kinase-dead PKC K/R (Fig. 3B) or the PKC inhibitor GF109203X (data not shown). In contrast, expression of the Vav variant Vav1-249 inhibited CD3/CD28-triggered NF-B activation but failed to impair PKC A/E-induced transcription (Fig. 3B).

View larger version (30K): [in this window] [in a new window]   Fig. 3.   Analysis of the signaling pathways mediating the Vav/PKC synergism. A, Jurkat cells were transfected with Vav and/or PKC A/E (5 µg, respectively) and 10-µg tagged DN forms of signaling and adaptor proteins as shown. 18 h later, cell extracts were prepared and analyzed for luciferase activity (upper panel) and protein expression (lower panel). To allow comparison, full activation by Vav, PKC, or both was arbitrarily set as 100%. Mean values of up to five independent experiments are shown; bars indicate standard deviations. B, Jurkat cells were transfected with active and inactive Vav and PKC expression vectors as shown. The next day, cells were stimulated by CD3/CD28 antibodies for 8 h as indicated, and luciferase activity was determined. Results are expressed as average -fold activation relative to vector-transfected cells; error bars indicate standard deviations. Three independent experiments were performed in duplicate.

Vav and PKC were found to be constitutively associated in T cells (20, 30). To map the Vav domain mediating this interaction, we expressed the FLAG-tagged Vav protein and various mutants thereof in Jurkat cells. After immunoprecipitation of the endogenous PKC protein, the associated Vav proteins were detected by immunoblotting (Fig. 4A). These experiments revealed that N-terminally deleted Vav variants were still able to coprecipitate with Vav, whereas Vav319-356 (lacking the Dbl homology domain) displayed an impaired Vav-PKC interaction. Vav501-845 showed only a faint residual coprecipitation with PKC, revealing the importance of the C-terminal portion for this protein-protein interaction. To address the question whether the mutual binding of both proteins is affected by T cell stimulation events, Jurkat cells were stimulated by CD3 and CD28 antibodies either alone or in combination. Coprecipitation experiments revealed that triggering of the T cell receptor alone did not affect constitutive PKC-Vav binding. In contrast, CD28 stimulation resulted in a transient dissociation of both proteins, starting from 3 to 5 min after stimulation. CD3/CD28 costimulation resulted in a loss of Vav-PKC interaction (Fig. 4B). Remarkably, the kinetics of the dissociation process were faster, and the reassociation process was slower when compared with CD28 stimulation. Employing a similar experimental approach, constitutive binding between Vav and PKC and CD28- or CD3/CD28-induced dissociation of this complex was also observed in primary human T cells (Fig. 4C).

View larger version (38K): [in this window] [in a new window]   Fig. 4.   Analysis of Vav-PKC interaction. A, Jurkat cells were transfected with the indicated FLAG-tagged Vav expression vectors as indicated. The following day, cell lysates were prepared, PKC was isolated by immunoprecipitation (IP), and coprecipitating proteins were detected by Western blotting (upper panel). The position of Vav501-845 (arrowhead) and the antibody heavy chain are indicated. An aliquot of whole cell lysate (WCL) was analyzed by immunoblotting for expression of Vav proteins (lower panel). B, Jurkat cells were stimulated with the indicated combinations of CD3 and CD28 antibodies for the given time periods. Endogenous PKC was immunoprecipitated from cell lysates, and the coprecipitating Vav protein was detected by immunoblotting (upper panels). An aliquot of the lysate was analyzed by Western blotting for expression of Vav and PKC proteins (lower panels). C, primary human T cells were stimulated with CD3 and/or CD28 antibodies for 8 min and further analyzed as for B.

	DISCUSSION

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

Here we identify the PKC isoform  as a potent inducer of NF-B. PKC synergized with Vav for the activation of NF-B, a transcription factor required for the expression of numerous immunologically relevant target genes (16). Vav and PKC also cooperate for the induction of JNK, as well as transcription of the IL-2 (19) and IL-4 genes (20), thereby mediating a strong enhancement of upstream signals. Such signal amplification events may be important in the early phase of infection, when only low concentrations of pathogens are present. The described interaction between Vav and PKC (20, 30) was not confirmed by Villalba et al. (19), which may be because of differences in the lysis conditions or binding buffers. Here we show mutual binding and induced dissociation of both proteins in primary human T cells, thereby revealing the physiological importance of this regulatory protein-protein interaction. T cell costimulation leads to the dissociation of the Vav-PKC complex and the PTK-dependent phosphorylation and plasma membrane recruitment of Vav. Vav itself induces actin polymerization and TCR capping by a PKC-independent pathway, but these events are essential for the PKC translocation into the SMACs (19). Along this line, there is recent evidence that Vav expression promotes PKC translocation from the cytosol to the membrane and cytoskeleton (19). These results fit our finding that all inhibitors of PKC also abrogated the Vav/PKC-induced transcriptional synergism, suggesting that Vav is located upstream from PKC in the control of the pathway leading to synergistic NF-B activation. The downstream targets of PKC are largely unknown, and it remains to be investigated whether PKC acts directly on IKK, as described for several atypical PKCs and PKC (31). However, NF-B activation by Vav and PKC might not only be mediated by the overlapping synergism pathway but also on separate routes. Cyclosporin A inhibited exclusively the Vav-mediated NF-B activation, suggesting that only Vav, but not the transcriptional synergism, depends on Ca²⁺/calcineurin-dependent signaling steps. Similarly, DN forms of Rac and MKK4 impaired only Vav-dependent processes without affecting NF-B activation induced by the synergistic Vav/PKC module. The CD28-dependent dissociation of Vav and PKC indicates that mutual binding of both proteins is not required for synergistic NF-B activation. Along this line, Vav501-845 was unable to efficiently bind to PKC, but still synergized with PKC for NF-B activation. The signal(s) triggering this dissociation is presently not identified. One possibility is a PKC-mediated phosphorylation of Vav, but we failed to detect this by in vitro and in vivo phosphorylation experiments (data not shown). Alternatively, the dissociation may be regulated by the 14-3-3- protein, which prevents the costimulation-induced translocation of PKC (32). Another candidate is Lck, a regulator of PKC function (33). Vav/PKC acted preferentially on IKK, which is in line with results from gene disruption experiments showing a predominant role of IKK for stimulus-induced phosphorylation and degradation of IB- (34). It remains to be seen in future studies whether Vav/PKC targets the "classical" IKC consisting of IKK, IKK, and IKK proteins or differentially composed IKK complexes containing the recently discovered IKK (35).

	ACKNOWLEDGEMENTS

We thank Dr. Susanne Bacher and Ingrid Fryson for helpful comments on the manuscript, Dominik Welsch for perfect technical assistance, Dr. Raoul Breitkreutz for help with the isolation of primary T lymphocytes, and Drs. S. Gutkind, R. Davis, M. Karin, and C. Miceli for generously providing plasmids.

	FOOTNOTES

^* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed. Tel.: 49-6221-423725; Fax: 49-6221-423746; E-mail: L.Schmitz@DKFZ.de.

Published, JBC Papers in Press, June 21, 2000, DOI 10.1074/jbc.C000177200

² O. Dienz, unpublished observation.

	ABBREVIATIONS

The abbreviations used are: TCR, T cell receptor; IKK(s), IB kinase(s); PTK(s), protein tyrosine kinase(s); SMAC(s), supramolecular activation complex(es); GEF, GDP/GTP exchange factor; IKC(s), IB kinase complex(es); IKKKs, IKK kinases; EMSAs, electrophoretic mobility shift assays; DN, dominant negative; JNK, c-Jun NH₂-terminal kinase; GST, glutathione S-transferase; WT, wild type; MEKK1, mitogen-activated protein kinase/extracellular signal-regulated kinase kinase; NIK, NF-B-inducing kinase; MLK3, mixed lineage kinase.

	REFERENCES

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				L. L. Molinero, M. B. Fuertes, M. V. Girart, L. Fainboim, G. A. Rabinovich, M. A. Costas, and N. W. Zwirner NF-{kappa}B Regulates Expression of the MHC Class I-Related Chain A Gene in Activated T Lymphocytes J. Immunol., November 1, 2004; 173(9): 5583 - 5590. [Abstract] [Full Text] [PDF]

				R. Stilo, D. Liguoro, B. Di Jeso, S. Formisano, E. Consiglio, A. Leonardi, and P. Vito Physical and Functional Interaction of CARMA1 and CARMA3 with I{kappa} Kinase {gamma}-NF{kappa}B Essential Modulator J. Biol. Chem., August 13, 2004; 279(33): 34323 - 34331. [Abstract] [Full Text] [PDF]

				N. N. Berg-Brown, M. A. Gronski, R. G. Jones, A. R. Elford, E. K. Deenick, B. Odermatt, D. R. Littman, and P. S. Ohashi PKC{theta} Signals Activation versus Tolerance In Vivo J. Exp. Med., March 15, 2004; 199(6): 743 - 752. [Abstract] [Full Text] [PDF]

				M. L. SCHMITZ, S. BACHER, and O. DIENZ NF-{kappa}B activation pathways induced by T cell costimulation FASEB J, December 1, 2003; 17(15): 2187 - 2193. [Abstract] [Full Text] [PDF]

				M. G. QUARANTA, B. MATTIOLI, F. SPADARO, E. STRAFACE, L. GIORDANI, C. RAMONI, W. MALORNI, and M. VIORA HIV-1 Nef triggers Vav-mediated signaling pathway leading to functional and morphological differentiation of dendritic cells FASEB J, November 1, 2003; 17(14): 2025 - 2036. [Abstract] [Full Text] [PDF]

				J. A. Cook, L. Albacker, A. August, and A. J. Henderson CD28-dependent HIV-1 Transcription Is Associated with Vav, Rac, and NF-{kappa}B Activation J. Biol. Chem., September 12, 2003; 278(37): 35812 - 35818. [Abstract] [Full Text] [PDF]

				U. E. Dreikhausen, K. Gorf, K. Resch, and M. Szamel Protein kinase C{beta}1, a major regulator of TCR-CD28-activated signal transduction leading to IL-2 gene transcription and secretion Int. Immunol., September 1, 2003; 15(9): 1089 - 1098. [Abstract] [Full Text] [PDF]

				E. Piccolella, F. Spadaro, C. Ramoni, B. Marinari, A. Costanzo, M. Levrero, L. Thomson, R. T. Abraham, and L. Tuosto Vav-1 and the IKK{alpha} Subunit of I{kappa}B Kinase Functionally Associate to Induce NF-{kappa}B Activation in Response to CD28 Engagement J. Immunol., March 15, 2003; 170(6): 2895 - 2903. [Abstract] [Full Text] [PDF]

				O. Dienz, A. Moller, A. Strecker, N. Stephan, P. H. Krammer, W. Droge, and M. L. Schmitz Src Homology 2 Domain-Containing Leukocyte Phosphoprotein of 76 kDa and Phospholipase C{gamma}1 Are Required for NF-{kappa}B Activation and Lipid Raft Recruitment of Protein Kinase C{theta} Induced by T Cell Costimulation J. Immunol., January 1, 2003; 170(1): 365 - 372. [Abstract] [Full Text] [PDF]

				M. Matsumoto, T. Yamada, S. K. Yoshinaga, T. Boone, T. Horan, S. Fujita, Y. Li, and T. Mitani Essential Role of NF-{kappa}B-Inducing Kinase in T Cell Activation Through the TCR/CD3 Pathway J. Immunol., August 1, 2002; 169(3): 1151 - 1158. [Abstract] [Full Text] [PDF]

				M. Villalba, K. Bi, J. Hu, Y. Altman, P. Bushway, E. Reits, J. Neefjes, G. Baier, R. T. Abraham, and A. Altman Translocation of PKC{theta} in T cells is mediated by a nonconventional, PI3-K- and Vav-dependent pathway, but does not absolutely require phospholipase C J. Cell Biol., April 15, 2002; 157(2): 253 - 263. [Abstract] [Full Text] [PDF]

				H. Ren, A. Schmalstieg, N. S. C. van Oers, and R. B. Gaynor I-{kappa}B Kinases {alpha} and {beta} Have Distinct Roles in Regulating Murine T Cell Function J. Immunol., April 15, 2002; 168(8): 3721 - 3731. [Abstract] [Full Text] [PDF]

				A. L. Mora, S. Stanley, W. Armistead, A. C. Chan, and M. Boothby Inefficient ZAP-70 Phosphorylation and Decreased Thymic Selection In Vivo Result from Inhibition of NF-{kappa}B/Rel J. Immunol., November 15, 2001; 167(10): 5628 - 5635. [Abstract] [Full Text] [PDF]

				D. Krappmann, A. Patke, V. Heissmeyer, and C. Scheidereit B-Cell Receptor- and Phorbol Ester-Induced NF-{kappa}B and c-Jun N-Terminal Kinase Activation in B Cells Requires Novel Protein Kinase C's Mol. Cell. Biol., October 1, 2001; 21(19): 6640 - 6650. [Abstract] [Full Text] [PDF]

				A. Long, D. Kelleher, S. Lynch, and Y. Volkov Cutting Edge: Protein Kinase C{{beta}} Expression Is Critical for Export of IL-2 from T Cells J. Immunol., July 15, 2001; 167(2): 636 - 640. [Abstract] [Full Text] [PDF]

				T. M. Herndon, X. C. Shan, G. C. Tsokos, and R. L. Wange ZAP-70 and SLP-76 Regulate Protein Kinase C-{{theta}} and NF-{{kappa}}B Activation in Response to Engagement of CD3 and CD28 J. Immunol., May 1, 2001; 166(9): 5654 - 5664. [Abstract] [Full Text] [PDF]

				A. Moller, O. Dienz, S. P. Hehner, W. Droge, and M. L. Schmitz Protein Kinase C theta Cooperates with Vav1 to Induce JNK Activity in T-cells J. Biol. Chem., June 1, 2001; 276(23): 20022 - 20028. [Abstract] [Full Text] [PDF]

				M. Villalba, K. Bi, J. Hu, Y. Altman, P. Bushway, E. Reits, J. Neefjes, G. Baier, R. T. Abraham, and A. Altman Translocation of PKC{theta} in T cells is mediated by a nonconventional, PI3-K- and Vav-dependent pathway, but does not absolutely require phospholipase C J. Cell Biol., April 15, 2002; 157(2): 253 - 263. [Abstract] [Full Text] [PDF]

This Article